Company:  BIOLASE, INC (BIOL)
Form Type:  10-Q
Filing Date:  11/10/2011 
CIK:  0000811240 
Address:  4 CROMWELL 
City, State, Zip:  IRVINE, California 92618 
Telephone:  949-361-1200 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$2.17  
Change: 
-0.03 (-1.36%)  
Trade Time: 
Apr 24  
Market Cap: 
$81.18M
Description of Business
We are a biomedical company that develops, manufactures, and markets lasers in dentistry and medicine and also markets and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners, and in-office, chair-side milling machines and three-dimensional (�3-D�) printers; products that are focused on technologies that advance the practice of dentistry and medicine. Our proprietary dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other specialists to perform a broad range of dental procedures, including cosmetic, restorative, and complex surgical applications. Our systems are designed to provide clinically superior performance for many types of dental procedures with less pain and faster recovery times than are generally achieved with drills, scalpels, and other conventional instruments. We have clearance from the U.S.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I. FINANCIAL INFORMATION
      ITEM 1. FINANCIAL STATEMENTS
        BALANCE SHEET
        INCOME STATEMENT
        CASH FLOW
        NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
      ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
      FINANCIAL STATEMENTS
        CASH FLOW
      ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      ITEM 4. CONTROLS AND PROCEDURES.
    PART II. OTHER INFORMATION.
      ITEM 1. LEGAL PROCEEDINGS.
      ITEM 1A. RISK FACTORS.
      ITEM 6. EXHIBITS
    SIGNATURES
  EXHIBIT 31.1
    CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
  EXHIBIT 31.2
    CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
  EXHIBIT 32.1
    CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
  EXHIBIT 32.2
    CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
BROKERAGE PARTNERS